Medicines for Europe Statement on Unitary SPC Legislative Process

19 November 2024

Joint Industry Statement on EU-Mercosur Negotiations

18 November 2024

Council adoption of Urban Waste Water Treatment Directive will generate a tsunami of essential and critical medicine shortages across Europe

5 November 2024

New report highlights market access barriers for EU-based generic and biosimilar companies in third countries

31 October 2024

Urban Wastewater Treatment Directive risks undoing Europe’s efforts to improve the availability, affordability and accessibility of medicines

17 October 2024

Medicines for Europe delegation leads on manufacturing, sustainability and access at CPHI congress

8 October 2024

EU Critical Medicines Act must protect secure supply of essential medicines

26 September 2024

Elisabeth Stampa: ‘Many drugs that used to be produced in Europe are now manufactured in Asia. This makes us vulnerable to shortages’

2 September 2024

The president of Medicines for Europe considers that the supply […]

Availability of Treatment in Slovakia within the framework of European Legislation – Expert Forum Brings Solutions

24 June 2024

The international conference Expert Forum, organized by the GENAS association, […]

Prioritising access and EU solidarity should drive Health Ministers’ agenda in next EU talks

19 June 2024